Skip to main content

Table 1 Main evaluated participants’ criteria

From: Predictors of early rebleeding after endoscopic therapy of first variceal bleeding in liver cirrhosis

Participants’ criteria Total
n=400
Rebleeding
n=96
No rebleeding
n=304
Sig.
Demographic criteria  
• Age (years) Mean (SD) 56 (8.1) 56.8 8.2 56 7.9 0.367
• Sex • Male Count (%) 268 67% 59 61.5% 209 68.8% 0.185
• Female Count (%) 132 33% 37 38.5% 95 31.2%
Patients clinical presentation  
• Hematemesis Count (%) 178 44.5% 55 57.3% 123 40.5% 0.007
• Melena Count (%) 102 25.5% 15 15.6% 87 28.6%
• Combined hematemesis and melena Count (%) 120 30% 26 27.1% 94 30.9%
Liver functions  
• ALT (IU/L) Mean (SD) 39 (11.7) 41.1 10.6 38.6 11.9 0.052
• AST (IU/L) Mean (SD) 44 (13.8) 44.8 13 44.3 14.2 0.739
• Serum albumin (gm/dl) Mean (SD) 3.32 (0.26) 3.12 0.23 3.33 0.25 < 0.0001
• Serum bilirubin (mg/dl) Median (IQR) 1.5 (0.6) 1.6 0.4 1.45 0.6 < 0.0001
• Prothrombin concentration (%) Median (IQR) 71 (9) 68 6 71 9 < 0.0001
• Child-Pugh score Median (QR) 7 (2) 8 1 7 2 < 0.0001
• Child-Pugh grade • Child A Count (%) 136 34% 10   126   < 0.0001
• Child B Count (%) 247 61.75% 87   169  
• Child C Count (%) 17 4.25% 8   9  
Radiological parameters  
• Spleen diameter (cm) Median (IQR) 16.3 (2.6) 17 2 16 2.2 < 0.0001
• Ascites • No ascites Count (%) 148 37% 11 11.5% 137 45.1% < 0.0001
• Easy to treat Count (%) 228 57% 70 72.9% 158 52%
• Difficult to treat Count (%) 24 6% 15 15.6% 9 3%
• PVD (mm) Median (IQR) 13.5 (4.8) 15.7 4.1 12.3 4.1 < 0.0001
• PVV (cm/s) Median (IQR) 14 (7) 11 6 16 6 < 0.0001
Other laboratory parameters  
• Serum creatinine (mg/dl) Median (IQR) 1.2 (0.2) 1.2 0.2 1.2 0.2 0.292
• Platelets (× 103/mm3) Median (IQR) 145 (54) 95 36 154 37 < 0.0001
• Hemoglobin (g/dl) Median (IQR) 9.8 (0.9) 9.6 1 9.8 0.9 0.501
Endoscopic parameters  
• Variceal form (F) • F1 Count (%) 131 32.75% 9 9.4% 122 40.1% < 0.0001
• F2 Count (%) 150 37.5% 34 35.4% 116 38.2%
• F3 Count (%) 119 29.75% 53 55.2% 66 21.7%
• Variceal location (L) • L1 Count (%) 246 61.5% 47 49% 199 65.5% 0.013
• L2 Count (%) 141 35.25% 44 45.8% 97 31.9%
• L3 Count (%) 13 3.25% 5 5.2% 8 2.6%
• Red color signs • Absent Count (%) 196 49% 25 26% 171 56.3% < 0.0001
• Not extensive Count (%) 160 40% 36 37.5% 124 40.8%
• Extensive Count (%) 44 11% 35 36.5% 9 3%
• Gastric extension Count (%) 116 29% 34 29.3% 82 70.7% 0.112
• Modality of bleeding control • EBL Count (%) 185 46.25% 42 43.8% 143 47% 0.573
• EIT Count (%) 215 53.75% 54 56.2% 161 53%
  1. ALT alanine aminotransferase, AST aspartate aminotransferase, PVD portal vein diameter, PVV portal vein velocity, EBL endoscopic band ligation, EIT endoscopic injection therapy